ライフサイエンスコーパス: Phoenix

1 est-incidence areas were in the periphery of Phoenix.

2 ied just over half (54%) of census tracts in Phoenix.

3 perform susceptibility testing using the BD Phoenix.

4 explore future water-shortage conditions in Phoenix.

5 t a single most likely or optimal future for Phoenix.

6 concentration higher and MICs determined by Phoenix 1 log2 concentration lower.

7 o the species level: MALDI Biotyper, 46%; BD Phoenix, 35%; and API 20 Strep, 26%.

8 clavulanate disk augmentation (9/19) and BD Phoenix (5/19).

9 MIC value of 1 mg/liter (74.1%), whereas the Phoenix (76%) and Vitek 2 (20%) systems had a tendency t

10 ing" a likely carbapenemase were 100%/0% (BD Phoenix), 82 to 85%/6 to 19% (MicroScan), and 74%/38% (V

11 gement of Platelet Inhibition), and CHAMPION PHOENIX (A Clinical Trial Comparing Cangrelor to Clopido

12 erminal kinase pathway when transfected into Phoenix-A cells (derivatives of 293 cells), similar to m

13 In addition, in Phoenix-A, NIH-3T3, and Hela cells, overexpression of wi

14 In Experiment 1, the dolphins Phoenix and Akeakamai processed the identity of a cued o

15 For the 308 common isolates, the BD Phoenix and Bruker Biotyper correctly identified 294 (95

16 For species identification, the BD Phoenix and Bruker Biotyper correctly identified 93% of

17 SI tests, were the reference methods for the Phoenix and VITEK 2 evaluations.

18 Current BD Phoenix and Vitek 2 methodologies were assessed as scree

19 The inclusion of cefoxitin in the Phoenix and Vitek 2 panels has optimized the detection o

20 acillin susceptibility," ranging from 54.1% (Phoenix) and 83.8% (Vitek 2) to 92.8% (WalkAway).

21 in duplicate by automated broth dilution (BD Phoenix) and disc diffusion.

22 ial MIC testing systems (MicroScan, Vitek 2, Phoenix, and Etest) to detect vancomycin MIC values of <

23 all 3 tertiary academic centers (Rochester, Phoenix, and Jacksonville) were included in the study.

24 , we tested the abilities of the Vitek 2, BD Phoenix, and Kirby Bauer disk diffusion tests to detect

25 AM trial at three medical centres in Boston, Phoenix, and Los Angeles, USA.

26 tended to be more accurate than the Vitek 2, Phoenix, and MicroScan automated systems; but errors wer

27 The BD Phoenix AP instrument reduced the manual setup time for

28 Using Phoenix, Arizona light rail as a case study, an integrat

29 Samples were collected in Phoenix, Arizona, at an ambulatory clinic and at retail

30 1,500-3,500 square feet in area, located in Phoenix, Arizona, built in 2002 and retired in 2051.

31 th counties of Wisconsin; and in 2005 in the Phoenix, Arizona, metropolitan area.

32 dical Center, a 650-bed teaching hospital in Phoenix, Arizona.

33 onal dispatch centers servicing metropolitan Phoenix, Arizona.

34 ing data on heat-related hospitalizations in Phoenix, Arizona.

35 nual meeting of the Society of Toxicology in Phoenix, Arizona.

36 e enrolled 782 patients through hospitals in Phoenix, Arizona; Boston; and Pittsburgh; 489 had histol

37 Paul, Minnesota; Philadelphia, Pennsylvania; Phoenix, Arizona; Seattle, Washington; and St. Louis, Mi

38 From these data, the Phoenix AST results demonstrated a high degree of agreem

39 We evaluated the Phoenix automated microbiology system (BD Diagnostic Sys

40 The performance of the BD Phoenix Automated Microbiology System (BD Diagnostic Sys

41 The Phoenix automated microbiology system (BD Diagnostics, S

42 level using standard biochemical tests and a Phoenix automated microbiology system (BD Diagnostics, S

43 ity testing was initially performed with the Phoenix automated microbiology system (BD Diagnostics, S

44 iety of phenotypic methods, including the BD Phoenix automated microbiology system (BD Diagnostics, S

45 This multicenter study evaluated the BD Phoenix Automated Microbiology System STREP panel (BD Di

46 We compared the BD Phoenix automated microbiology system to the Bruker Biot

47 Joseph's Hospital and Medical Center (Phoenix, AZ) (6 males and 6 females), using a head-mount

48 g medical records from Mayo Clinic Hospital (Phoenix, AZ) and contacting local infectious diseases sp

49 (Translational Genomics Research Institute, Phoenix, AZ) and Dr. Nicholas Dracopoli (Bristol-Myers S

50 , Raleigh, NC, St. Paul, MN, Pittsburgh, PA, Phoenix, AZ, and Portland, OR) in two physiographic sett

51 C, Okefenokee, GA, Bondville, IL, Mingo, MO, Phoenix, AZ, San Gabriel, CA, Crater Lake National Park,

52 done at the Banner Alzheimer's Institute in Phoenix, AZ, USA.

53 can WalkAway (Dade, West Sacramento, CA), BD Phoenix (BD Diagnostic Systems, Sparks, MD), VITEK (bioM

54 The BD Phoenix (BD Diagnostics, Sparks, MD) and Vitek 2 (bioMer

55 ns), 91.9% (Vitek 2; bioMerieux), and 64.9% (Phoenix, BD).

56 altonics), API 20 Strep (bioMerieux), and BD Phoenix (Becton, Dickinson).

57 BD Phoenix, bioMerieux Vitek 2, and Beckman Coulter MicroSc

58 ern, PA], Trep-Sure enzyme immunoassay [EIA; Phoenix Biotech, Oakville, Ontario, Canada], Trep-Chek E

59 rep-Chek EIA [Phoenix Biotech], Trep-ID EIA [Phoenix Biotech], and Treponema ViraBlot IgG [Viramed Bi

60 , Oakville, Ontario, Canada], Trep-Chek EIA [Phoenix Biotech], Trep-ID EIA [Phoenix Biotech], and Tre

61 ipulation time per isolate was 89.5 s for BD Phoenix by the use of the AP instrument and 101 s for Vi

62 benefits of transit-oriented developments in Phoenix can range from 1.7 to 230 Gg CO2e depending on t

63 Our new tool, pHoenix, can functionally replace endogenous proton pump

64 base tissues of the Canary Island date palm (Phoenix canariensis) contain lignins with the most compl

65 In CHAMPION PHOENIX, cangrelor reduced the odds of major adverse car

66 ength IL-5Ralpha and betac were expressed in Phoenix cells as chimeric proteins fused to enhanced cya

67 aneous Coronary Intervention [PCI] [CHAMPION PHOENIX] [CHAMPION]: NCT01156571).

68 ve, double-blind, active-controlled CHAMPION PHOENIX (Clinical Trial Comparing Cangrelor to Clopidogr

69 HAMPION-PCI, CHAMPION-PLATFORM, and CHAMPION-PHOENIX) compared cangrelor with control (clopidogrel or

70 The BD Phoenix correctly identified 363 (83%) and 330 (75%) iso

71 The current study evaluated the automated BD Phoenix CPO Detect and the manual bioMerieux Rapidec Car

72 Only BD Phoenix CPO Detect classified carbapenemases.

73 BD Phoenix CPO Detect provides novel advantages such as aut

74 BD Phoenix CPO Detect was 68.6% specific and Rapidec Carba

75 hemical recurrent prostate cancer defined by Phoenix criteria after external-beam radiotherapy or bra

76 t, was defined from entry until PSA relapse (Phoenix criteria) and clinical relapse by imaging or dea

77 erapeutic Radiology and Oncology [ASTRO] and Phoenix criteria), local failure, distant metastasis, ca

78 ciety for Therapeutic Radiation Oncology and Phoenix criteria.

79 Dates (Phoenix dactylifera L.) are distributed worldwide as maj

80 The date palm (Phoenix dactylifera L.), famed for its sugar-rich fruits

81 Date palms (Phoenix dactylifera) are the most significant perennial

82 gorical agreement levels for VITEK 2, Etest, Phoenix, disk diffusion, and VITEK were 93.0%, 90.0%, 89

83 The Phoenix ESBL confirmatory test and unmodified expert sys

84 The VITEK 2 and Phoenix extended-spectrum beta-lactamase (ESBL) detectio

85 An analysis of the Phoenix Fire Department Regional Dispatch Center records

86 med out-of-hospital cardiac arrests from the Phoenix Fire Department Regional Dispatch Center text fi

87 Bruker Biotyper overall outperformed the BD Phoenix for identification of gram-negative bacilli to t

88 ver, the Bruker Biotyper outperformed the BD Phoenix for identification of infrequently isolated gram

89 -GALV), and we evaluated vectors produced by Phoenix-GALV for their ability to transduce hematopoieti

90 dotype retrovirus vectors produced by either Phoenix-GALV or by the NIH 3T3-derived packaging cell li

91 with a gibbon ape leukemia virus pseudotype (Phoenix-GALV), and we evaluated vectors produced by Phoe

92 ion of baboon CD34(+) cells, suggesting that Phoenix-GALV-derived oncoretroviral vectors may be even

93 ing cells was significantly higher using the Phoenix-GALV-derived vector as compared with the PG13-de

94 In 3 additional baboons we compared Phoenix-GALV-derived vectors to more recently developed

95 tilineage engraftment of cells transduced by Phoenix-GALV-pseudotype vectors.

96 a personal cost and through the existence of phoenix genes, which rescue cooperative systems from sel

97 n minutes in up to 96% yield in an automated Phoenix high-temperature and high-pressure continuous fl

98 ions (ASTRO HR 1.073 [1.018-1.131], p=0.008; Phoenix HR 1.073 [1.014-1.134], p=0.014); and any failur

99 overall percentages of agreement between the Phoenix ID results and the MicroScan results at the genu

100 rnaround times for positive cultures, and BD Phoenix identification and antimicrobial susceptibility

101 rall, there was good correlation between the Phoenix instrument and the MicroScan system for the ID a

102 We evaluated the performance of the Phoenix instrument in comparison with that of the MicroS

103 e); one false positive was obtained with the Phoenix instrument.

104 The discovery by the Phoenix Lander of calcium and magnesium perchlorates in

105 has been identified in the soils around the Phoenix landing site by scanning calorimetry showing an

106 The Wet Chemistry Laboratory on the Phoenix Mars Lander performed aqueous chemical analyses

107 (79 men, 138 women) were recruited from the Phoenix metropolitan area (age range = 17-92 years).

108 automated susceptibility testing systems (BD Phoenix, MicroScan WalkAway, Vitek, and Vitek 2; two lab

109 The Phoenix mission investigated patterned ground and weathe

110 -Line Data Registry (COLD Registry) used the Phoenix (nadir + 2 ng/ml definition) to report 5-year bi

111 aneous Coronary Intervention [PCI] [CHAMPION PHOENIX]; NCT01156571).

112 ploying disk augmentation, Etest, and the BD Phoenix NMC/ID-132 panel.

113 ll, as additional vesicle acidification with pHoenix only slightly increased the quantal size.

114 Organisms were inoculated onto the Phoenix panel according to the manufacturer's instructio

115 by the reference methods were 99.8% for the Phoenix panels and 99.7% for the Vitek 2 cards.

116 The Phoenix panels were inoculated according to the manufact

117 enterococci were correctly identified by the Phoenix panels.

118 f over $520 (Seattle) to a net loss of $800 (Phoenix) per building annually.

119 costs range from -$1.60 (Seattle) to $11.9 (Phoenix) per m(3) of rainwater yield, resulting in a pot

120 . aureus isolates were tested in parallel on Phoenix PMIC/ID-102 panels and Vitek 2 AST-GP66 cards.

121 e optimal management of platelet inhibition) PHOENIX randomized 11 145 patients to cangrelor or clopi

122 In Experiment 2, Phoenix reliably responded to a cued object in alternate

123 , the rate of complete agreement between the Phoenix results and the MicroScan results was 89.1%; the

124 , the rate of complete agreement between the Phoenix results and the MicroScan results was 97%; the r

125 oliferation of surrounding cells through the Phoenix Rising (PR) pathway.

126 mmercial MIC test systems (Etest, MicroScan, Phoenix, Sensititre, Vitek Legacy, and Vitek 2 systems)

127 able is highly variable within the potential Phoenix spacecraft landing ellipses, and is likely to be

128 The Mars Phoenix spacecraft measurements of carbon isotopes [refe

129 nt modern human diets, including date palms (Phoenix spp.), legumes, and grass seeds (Triticeae), whe

130 reement (0 +/- dilution) was highest for the Phoenix system (66.2%) and the MicroScan turbidity metho

131 , and G; and 20 other streptococci) with the Phoenix system and a broth microdilution reference metho

132 rument reduced the manual setup time for the Phoenix system by 50%.

133 The Phoenix system compares favorably to traditional methods

134 The Phoenix system compares favorably to traditional methods

135 All six were flagged by the Phoenix system expert rules.

136 We evaluated the accuracy of the BD Phoenix system for the identification (ID) and antimicro

137 The Phoenix system is a reliable method for the ID and AST o

138 The Phoenix system provided reliable and rapid AST results f

139 nal biochemical testing, the accuracy of the Phoenix system was determined to be 100%.

140 In 16 instances (9 on the Phoenix system, 7 on the Vitek 2 system), an oxacillin M

141 lenge isolates, versus the 6 detected by the Phoenix system.

142 n-resistant enterococci were detected by the Phoenix system.

143 isolates were incorrectly identified by the Phoenix system; 10 of these were incorrectly identified

144 y undercalled resistance); the MicroScan and Phoenix systems and Etest tended to categorize susceptib

145 The Biotyper and Phoenix systems correctly identified 99.9% and 99.5% to

146 The Bruker Biotyper and BD Phoenix systems were evaluated for identification of 1,0

147 hird arm of the study was conducted with the Phoenix test using two normally inactive expert rules in

148 , although fewer VMEs were observed with the Phoenix than with the Vitek 2.

149 s, designated phx (for the mythological bird Phoenix that rises from its ashes), were isolated.

150 For Phoenix, the EAs of individual antimicrobial agents rang

151 and pAmpC genes for Etest (four of five), BD Phoenix (three of five), and disk augmentation (one of f

152 to cangrelor or clopidogrel in the CHAMPION PHOENIX trial (Cangrelor versus Standard Therapy to Achi

153 Management of Platelet Inhibition (CHAMPION) PHOENIX trial demonstrated superiority of cangrelor in r

154 In the large-scale CHAMPION PHOENIX trial, the occurrence of IPST was strongly predi

155 Management of Platelet Inhibition (CHAMPION PHOENIX) trial randomized 11,145 patients undergoing ele

156 HAMPION PCI, CHAMPION PLATFORM, and CHAMPION PHOENIX) trials of patients undergoing elective or nonel

157 d to other organelles, as demonstrated for a pHoenix variant that allows light-activated acidificatio

158 using disk diffusion, Etest, as well as the Phoenix, Vitek 2, and MicroScan automated systems, and c

159 The average times to results for Phoenix, Vitek 2, and the manual methods were 12.1 h, 9.

160 ined by the reference method) for MicroScan, Phoenix, VITEK 2, Etest, and VITEK were 99.0%, 95.8%, 92

161 The categorical agreements (CA) of Phoenix, Vitek 2, MicroScan, and Etest for penicillin we

162 The overall CA for Phoenix was 99.3% (1 very major error [VME] and 29 minor

163 Phoenix was errorless on first trials in this task.

164 ermal and evolved gas analyzer (TEGA) aboard Phoenix were successful in detecting organics in the Mar

165 cies level, respectively, compared to the BD Phoenix, which identified only 69 (52%) and 45 (34%) iso

166 and noncompartmental PKs were analyzed using Phoenix WinNonlin.